Close Menu

NEW YORK – Thermo Fisher Scientific said on Monday that it has priced an offering of €1.2 billion ($1.33 billion) worth of euro-denominated senior notes.

The Waltham, Massachusetts-based company is offering €6 billion worth of senior notes with an interest rate of 1.75 percent per year and a due date of 2027, and €6 billion worth of senior notes with an interest rate of 2.375 percent per year and a due date of 2032.

The offering is expected to close on or about April 2, subject to customary closing conditions, and the notes will pay interest on an annual basis.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to the Wall Street Journal, the Food and Drug Administration may soon issue an Emergency Use Authorization for convalescent plasma to treat COVID-19 patients.

Minnesota police have used genetic genealogy to make an arrest in a 1986 cold case, reports NBC News.

Researchers have used CRISPR-Cas9 to efficiently target a cephalopod pigmentation gene, as they report in Current Biology.

In Science this week: chromatin accessibility of microglia during fetal development, and more.